Meet Our Featured Speakers
THE PREMIER FORUM FOR AI AND OMICS-DRIVEN APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
Welcome to PHARMA OMICS & AI 2026, an event that brings together industry leaders to explore how AI, ML, and multi-omics are transforming drug discovery, development, and real-world evidence.
The industry faces challenges such as biased and siloed data, limited scalability in multi-omics integration, and regulatory uncertainty. However, clearer methodologies and stronger data standards can drive faster therapy development, expand precision medicine, and reduce R&D costs.
Join us to gain practical insights, exchange ideas with peers, and help advance safe, effective, data-driven innovations across the pharmaceutical landscape.
key topics for
Emerging AI-driven solutions to overcome bioprocessing challenges
Learn how AI deployment in bioprocessing with PAT and digital twins reduces errors, supports predictive maintenance, and accelerates compliant batch release.
Advances in bioinformatics and omics for precision medicine and biomarkers
See how single-cell and spatial bioinformatics uncover disease pathways, reveal biomarkers, enable smarter trials, and inform treatment decisions.
Case studies highlighting data platforms for discovery and development
Explore innovative data platforms that break silos, streamline access, and add built-in checks to accelerate reliable AI and smarter decision-making in pharma.
Applying AI and ML to accelerate drug discovery, design, and development
Discover AI and ML across end-to-end R&D, from identifying targets and designing molecules to choosing sites, forecasting enrollment, and optimizing protocols.
Strategies to integrate multi-omics and patient-level data at scale
Find solutions to multi-omics integration challenges and link genomics, proteomics, and metabolomics with clinical data to deliver precision therapies at scale.
Upcoming AI regulations and safety standards across the Pharma lifecycle
Navigate FDA and EMA expectations for AI across the pharma lifecycle while building compliant, GxP-ready systems and pipelines for reliable implementation.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
RESEARCH
27 Feb 2026
Can Big Data Crack the Brain’s Toughest Diseases?MARKET TRENDS
19 Feb 2026
AI Multi-Omics Meets Market Reality CheckRESEARCH
13 Feb 2026
AI and Multi-Omics Join Forces to Rethink Drug DiscoveryINNOVATION
11 Feb 2026
NVIDIA Pushes AI Into the Heart of Drug Discovery
Takeda Turns to AI to Reshape Early Drug Discovery

INVESTMENT
9 Feb 2026
Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research
they've attended our events
Expert Speakers
Hongfeng Deng
Sanofi
Brett Hill
Arcturus Therapeutics
Daniel Dixon
TriLink BioTechnologies
Past Attendees
Sanofi
Hongene Biotech
TriLink BioTechnologies
Arranta Bio Holdings LLC
Aldevron
Orna Therapeutics
CATUG Biotechnology
DNA Script
Helix Biotech













